✦ LIBER ✦

Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders

✍ Scribed by Birschmann, I.; Klamroth, R.; Eichler, H.; Schenk, J.; Kirchmaier, C. M.; Halimeh, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dosing and effectiveness of recombinant

✍ G. Young; D. L. Cooper; R. Z. Gut; on behalf of the HTRS Investigators 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Single-dose (270 μg kg−1) recombinant ac

✍ B. PAN-PETESCH; P. LAGUNA; A. MITAL; J. STANLEY; M. F. TORCHET; S. Z. SALEK; P. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Recombinant activated factor VII safety

✍ C. NAKAR; D. L. COOPER; D. DiMICHELE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB